CliffBio
small molecule

MIRAPEX ER

PRAMIPEXOLE DIHYDROCHLORIDE

Loss of exclusivitySeptember 2029latest FDA-listed patent expiry
CompanyBoehringer Ingelheim →View the full company profile on CliffBio

Drug detail

Brand nameMIRAPEX ER
Active ingredientPRAMIPEXOLE DIHYDROCHLORIDE
Strength3.75MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJune 2011
Marketing statusDISCN

Listed patents

PatentExpiresType
8679533September 2029product
7695734April 2028product

More from Boehringer Ingelheim

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

MIRAPEX ER patent cliff — loss of exclusivity September 2029 | CliffBio